Skip to main content
. 2023 Jul 12;11:e41815. doi: 10.2196/41815

Table 3.

Patient Health Questionnaire-9 (PHQ-9) class characteristics.


PHQ class 1 (“stable high”; n=10) PHQ class 2 (“improving high”; n=17) PHQ class 3 (“improving moderate”; n=77) PHQ class 4 (“stable moderate”; n=56) PHQ class 5 (“improving low”; n=61)
Participants (n=221), n (%) 10 (4.52) 17 (7.69) 77 (34.84) 56 (25.34) 61 (27.6)
Age (years), mean (SD) 30.1 (13.92) 34.47 (13.31) 31.31 (11.43) 32.38 (13.48) 35.41 (13.01)
Baseline PHQ-9 score, mean (SD) 21.6 (2.95) 21.41 (2.58) 14.12 (3.52) 16.05 (2.94) 8 (3.61)
Week 12 PHQ-9 score, mean (SD) 21.4 (2.07) 7.88 (3.64) 6.64 (3.89) 13.64 (3.55) 3.64 (2.10)
Baseline GAD-7a score, mean (SD) 17.4 (3.47) 16.65 (3.00) 11.96 (5.03) 13.55 (4.32) 9.39 (4.14)
Week 12 GAD-7 score, mean (SD) 14.2 (5.31) 5.75 (3.11) 5.56 (3.80) 11.42 (4.46) 3.72 (3.58)
Sex (male), n (%) 1 (10) 6 (35) 25 (32) 16 (29) 15 (25)
Employment status (employed full time), n (%) 6 (60) 14 (82) 60 (78) 36 (64) 50 (82)
Psychiatric medication status (prescribed and taking), n (%) 7 (70) 12 (71) 29 (38) 25 (45) 14 (23)
Long-term condition (no), n (%) 8 (80) 12 (71) 61 (79) 45 (80) 50 (82)
Program type, n (%)

Comorbid 6 (60) 10 (59) 35 (45) 32 (57) 21 (34)

Depression 1 (10) 6 (35) 21 (27) 14 (25) 8 (13)

Anxiety 3 (30) 1 (6) 21 (27) 10 (18) 32 (52)

aGAD-7: Generalized Anxiety Disorder-7.